Status:

COMPLETED

Determinants of Age Related Breathing Instability During Non-Rapid-Eye-Movement (NREM) Sleep

Lead Sponsor:

VA Office of Research and Development

Conditions:

Sleep Apnea

Age

Eligibility:

All Genders

18-89 years

Phase:

NA

Brief Summary

The purpose for this research protocol was to examine the role of breathing control mechanisms that determine the development of sleep-disordered breathing in the elderly. This proposal focused on key...

Detailed Description

Sleep apnea-hypopnea syndrome (SAS) is a relatively common disorder in the US population with significant adverse health consequences. Despite the high prevalence of SAS in elderly individuals, the un...

Eligibility Criteria

Inclusion

  • Healthy older and young adults

Exclusion

  • Pregnancy,
  • history of active coronary artery disease-including stable and unstable angina,
  • recent myocardial infarction,
  • history of congestive heart failure,
  • stroke,
  • excessive daytime sleepiness with Epworth Sleepiness Scale of \>15
  • patient with OSA- (Obstructive sleep apnea) on therapy
  • depression,
  • schizophrenia,
  • untreated hypothyroidism,
  • diabetes on insulin,
  • seizure disorder,
  • intrinsic renal and liver disorders,
  • failure to give informed consent,
  • patients with evidence of pulmonary diseases based on history and abnormal pulmonary function testing, including obstructive (ratio of predicted forced expiratory volume to forced vital capacity, \<80% predicted) or restrictive lung disorders (total lung capacity \<80% predicted) with resting oxygen saturation of \<96% and kyphoscoliosis (chest wall deformities)
  • patients on certain medications including, opiates derivatives, stimulants, antidepressants, tranquilizers, anti-psychotic agents, theophylline and other central nervous system altering medications
  • history of alcohol or recreational drug use will also serve as grounds for exclusion,
  • patients with body mass index (BMI) \>34kg/m2
  • subjects with sleep apnea are already using continuous positive airway pressure for more than 7 days as therapy

Key Trial Info

Start Date :

October 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2015

Estimated Enrollment :

92 Patients enrolled

Trial Details

Trial ID

NCT00732199

Start Date

October 1 2008

End Date

April 1 2015

Last Update

June 28 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

John D. Dingell VA Medical Center, Detroit, MI

Detroit, Michigan, United States, 48201